These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
253 related articles for article (PubMed ID: 24024519)
1. Evaluation of the toxicity forecasting capability of EPA's ToxCast Phase I data: can ToxCast in vitro assays predict carcinogenicity? Benigni R J Environ Sci Health C Environ Carcinog Ecotoxicol Rev; 2013; 31(3):201-12. PubMed ID: 24024519 [TBL] [Abstract][Full Text] [Related]
2. In vitro cell transformation assays for an integrated, alternative assessment of carcinogenicity: a data-based analysis. Benigni R; Bossa C; Tcheremenskaia O Mutagenesis; 2013 Jan; 28(1):107-16. PubMed ID: 23132285 [TBL] [Abstract][Full Text] [Related]
3. Evaluation of high-throughput genotoxicity assays used in profiling the US EPA ToxCast chemicals. Knight AW; Little S; Houck K; Dix D; Judson R; Richard A; McCarroll N; Akerman G; Yang C; Birrell L; Walmsley RM Regul Toxicol Pharmacol; 2009 Nov; 55(2):188-99. PubMed ID: 19591892 [TBL] [Abstract][Full Text] [Related]
4. The Syrian hamster embryo cells transformation assay identifies efficiently nongenotoxic carcinogens, and can contribute to alternative, integrated testing strategies. Benigni R; Bossa C; Tcheremenskaia O; Battistelli CL; Giuliani A Mutat Res Genet Toxicol Environ Mutagen; 2015 Feb; 779():35-8. PubMed ID: 25813724 [TBL] [Abstract][Full Text] [Related]
5. In vitro perturbations of targets in cancer hallmark processes predict rodent chemical carcinogenesis. Kleinstreuer NC; Dix DJ; Houck KA; Kavlock RJ; Knudsen TB; Martin MT; Paul KB; Reif DM; Crofton KM; Hamilton K; Hunter R; Shah I; Judson RS Toxicol Sci; 2013 Jan; 131(1):40-55. PubMed ID: 23024176 [TBL] [Abstract][Full Text] [Related]
6. Evaluation of the ability of a battery of three in vitro genotoxicity tests to discriminate rodent carcinogens and non-carcinogens II. Further analysis of mammalian cell results, relative predictivity and tumour profiles. Kirkland D; Aardema M; Müller L; Makoto H Mutat Res; 2006 Sep; 608(1):29-42. PubMed ID: 16769241 [TBL] [Abstract][Full Text] [Related]
7. Analysis of Pfizer compounds in EPA's ToxCast chemicals-assay space. Shah F; Greene N Chem Res Toxicol; 2014 Jan; 27(1):86-98. PubMed ID: 24328225 [TBL] [Abstract][Full Text] [Related]
8. Alternatives to the carcinogenicity bioassay for toxicity prediction: are we there yet? Benigni R Expert Opin Drug Metab Toxicol; 2012 Apr; 8(4):407-17. PubMed ID: 22360376 [TBL] [Abstract][Full Text] [Related]
9. A perspective on current and future uses of alternative models for carcinogenicity testing. Goodman JI Toxicol Pathol; 2001; 29 Suppl():173-6. PubMed ID: 11695554 [TBL] [Abstract][Full Text] [Related]
10. How well can carcinogenicity be predicted by high throughput "characteristics of carcinogens" mechanistic data? Becker RA; Dreier DA; Manibusan MK; Cox LAT; Simon TW; Bus JS Regul Toxicol Pharmacol; 2017 Nov; 90():185-196. PubMed ID: 28866267 [TBL] [Abstract][Full Text] [Related]
11. Application of in vitro cell transformation assays in regulatory toxicology for pharmaceuticals, chemicals, food products and cosmetics. Vanparys P; Corvi R; Aardema MJ; Gribaldo L; Hayashi M; Hoffmann S; Schechtman L Mutat Res; 2012 Apr; 744(1):111-6. PubMed ID: 22342612 [TBL] [Abstract][Full Text] [Related]
12. Evaluation of reduced protocols for carcinogenicity testing of chemicals: report of a joint EPA/NIEHS workshop. Lai DY; Baetcke KP; Vu VT; Cotruvo JA; Eustis SL Regul Toxicol Pharmacol; 1994 Apr; 19(2):183-201. PubMed ID: 8041916 [TBL] [Abstract][Full Text] [Related]
13. International regulatory needs for development of an IATA for non-genotoxic carcinogenic chemical substances. Jacobs MN; Colacci A; Louekari K; Luijten M; Hakkert BC; Paparella M; Vasseur P ALTEX; 2016; 33(4):359-392. PubMed ID: 27120445 [TBL] [Abstract][Full Text] [Related]
14. Are tumor incidence rates from chronic bioassays telling us what we need to know about carcinogens? Gaylor DW Regul Toxicol Pharmacol; 2005 Mar; 41(2):128-33. PubMed ID: 15698536 [TBL] [Abstract][Full Text] [Related]
15. Exploring in vitro/in vivo correlation: lessons learned from analyzing phase I results of the US EPA's ToxCast Project. Benigni R; Bossa C; Giuliani A; Tcheremenskaia O J Environ Sci Health C Environ Carcinog Ecotoxicol Rev; 2010 Oct; 28(4):272-86. PubMed ID: 21069615 [TBL] [Abstract][Full Text] [Related]
16. An evaluation of 25 selected ToxCast chemicals in medium-throughput assays to detect genotoxicity. Kligerman AD; Young RR; Stankowski LF; Pant K; Lawlor T; Aardema MJ; Houck KA Environ Mol Mutagen; 2015 Jun; 56(5):468-76. PubMed ID: 25537651 [TBL] [Abstract][Full Text] [Related]
18. Assessment and validation of US EPA's OncoLogic® expert system and analysis of its modulating factors for structural alerts. Benigni R; Bossa C; Alivernini S; Colafranceschi M J Environ Sci Health C Environ Carcinog Ecotoxicol Rev; 2012; 30(2):152-73. PubMed ID: 22690713 [TBL] [Abstract][Full Text] [Related]
19. Economic benefits of using adaptive predictive models of reproductive toxicity in the context of a tiered testing program. Martin MT; Knudsen TB; Judson RS; Kavlock RJ; Dix DJ Syst Biol Reprod Med; 2012 Feb; 58(1):3-9. PubMed ID: 22239076 [TBL] [Abstract][Full Text] [Related]
20. Use of high-throughput in vitro toxicity screening data in cancer hazard evaluations by IARC Monograph Working Groups. Chiu WA; Guyton KZ; Martin MT; Reif DM; Rusyn I ALTEX; 2018; 35(1):51-64. PubMed ID: 28738424 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]